Advertisement

Sweet’s Syndrome

  • Marie-Dominique Vignon-Pennamen
Chapter

Abstract

Sweet’s syndrome is the prototypic neutrophilic dermatosis first reported in 1964 by Robert Douglas Sweet who describes a new dermatosis entitled an ‘acute febrile neutrophilic dermatosis”. Although the pathogenesis of Sweet’s syndrome still remains to be determined, this condition is now classified as an autoinflammatory disease.

References

  1. 1.
    Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol. 1964;76:349–56.CrossRefPubMedGoogle Scholar
  2. 2.
    Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol. 2014;178:48–56.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Sujobert P, Cuccuini W, Vignon-Pennamen D, Martin-Garcia N, Albertini AF, Uzunov M, Redjoul R, Dombret H, Raffoux E. Evidence of differenciation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients. J Invest Dermatol. 2013;133:1111–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Chavan RN, Cappel MA, Ketterling RP, Wada DA, Rochet NM, Knudson R, Gibson LE. Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescent in situ hybridization. J Am Acad Dermatol. 2014;70:1021–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol. 1988;6:1887–97.CrossRefPubMedGoogle Scholar
  6. 6.
    Cohen PR, Kurzrock R. Sweet’s syndrome and cancer. Clin Dermatol. 1993;11:149–57.CrossRefPubMedGoogle Scholar
  7. 7.
    von den Driesch P. Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994;31:535–56.CrossRefPubMedGoogle Scholar
  8. 8.
    Cohen PR, Kurzrock R. Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol. 2000;18:265–82.CrossRefPubMedGoogle Scholar
  9. 9.
    Cohen PR, Kurzrock R. Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol. 2003;42:761–78.CrossRefPubMedGoogle Scholar
  10. 10.
    Wallach D, Vignon-Pennamen MD. Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses. Br J Dermatol. 2015.  https://doi.org/10.1111/bjd.13955.
  11. 11.
    Costello MJ, Canizares O, Montague M, Buncke CM. Cutaneous manifestations of myelogenous leukemia. Arch Dermatol. 1955;71:605–14.CrossRefGoogle Scholar
  12. 12.
    Matta M, Malak J, Tabet E, Kurban AK. Sweet’s syndrome: systemic associations. Cutis. 1973;12:561–5.Google Scholar
  13. 13.
    Kemmett D, Hunter JA. Sweet’s syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol. 1990;23:503–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Hommel L, Harms M, Saurat JH. The incidence of Sweet’s syndrome in Geneva. Dermatology. 1993;187:303–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Sitjas D, Puig L, Cuatrecasas M, De Moragas JM. Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Int J Dermatol. 1993;32:261–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Chan HL, Lee YS, Kuo TT. Sweet’s syndrome: clinicopathologic study of eleven cases. Int J Dermatol. 1994;33:425–32.CrossRefPubMedGoogle Scholar
  17. 17.
    Fett DL, Gibson LE, Su WPD. Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc. 1995;70:234–40.CrossRefPubMedGoogle Scholar
  18. 18.
    Bourke JF, Keohane S, Long CC, Kemmett D, Davies M, Zaki I, Graham-Brown RA. Sweet’s syndrome and malignancy in the U.K. Br J Dermatol. 1997;137:609–13.CrossRefPubMedGoogle Scholar
  19. 19.
    Cho KH, Han KH, Kim SW, Youn SW, Youn JI, Kim BK. Neutrophilic dermatoses associated with myeloid malignancy. Clin Exp Dermatol. 1997;22:269–73.CrossRefPubMedGoogle Scholar
  20. 20.
    Neoh CY, Tan AW, Ng SK. Sweet’s syndrome: a spectrum of unusual clinical presentations and associations. Br J Dermatol. 2007;156:480–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Borges da Costa J, Silva R, Soares de Almeda L, Filipe P, Marques Gomes M. Sweet’s syndrome: a retrospective study of 42 admitted patients in a Portuguese hospital. Int J Dermatol. 2009;48:953–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Abbas O, Kibbi AG, Rubeiz N. Sweet’s syndrome: retrospective study of clinical and histologic features of 44 cases from a tertiary care center. Int J Dermatol. 2010;49:1244–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Wojcik AS, Nishimori FS, Santamaria JR. Sweet’s syndrome: a study of 23 cases. An Bras Dermatol. 2011;86:265–71.CrossRefPubMedGoogle Scholar
  24. 24.
    Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, associations and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69:557–64.CrossRefPubMedGoogle Scholar
  25. 25.
    Uilhein LC, Brandling-Bennett HA, Lio PA, Liang MG. Sweet syndrome in children. Pediatr Dermatol. 2012;29:38–44.CrossRefGoogle Scholar
  26. 26.
    Demitsu T, Tadaki T. Atypical neutrophilic dermatosis on the upper extremitiy affected by postmastectomy lymphedema: report of 2 cases. Dermatologica. 1991;183:230–3.CrossRefPubMedGoogle Scholar
  27. 27.
    Minocha R, Sebaratnam DF, Choi JY. Sweet’s syndrome following surgery: cutaneous trauma as a possible aetiological co-factor in neutrophilic dermatoses. Australas J Dermatol. 2015;56:e74–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet’s syndrome associated with myeloproloferative disorders. J Am Acad Dermatol. 1983;9:751–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Cooper PH, Innes DJ, Greer KE. Acute febrile neutrophilic dermatosis (Sweet’s syndrome) and myeloproliferative disorders. Cancer. 1983;51:1518–26.CrossRefPubMedGoogle Scholar
  30. 30.
    Strutton G, Weedon D, Robertson I. Pustular vasculitis of the hands. J Am Acad Dermatol. 1995;32:192–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Galaria NA, Junkins-Hopkins JM, Kligman D, James WD. Neutrophilic dermatosis of the dorsal hands: pustular vasculitis revisited. J Am Acad Dermatol. 2000;43:870–4.CrossRefPubMedGoogle Scholar
  32. 32.
    DiCaudo DJ, Connolly SM. Neutrophilic dermatosis (pustular vasculitis) of the dorsal hands. A report of 7 cases and review of the literature. Arch Dermatol. 2002;138:361–5.CrossRefPubMedGoogle Scholar
  33. 33.
    Cohen PR. Skin lesions of Sweet syndrome and its dorsal hand variant contain vasculitis. An oxymoron or an epiphenomenon? Arch Dermatol. 2002;138:400–3.CrossRefPubMedGoogle Scholar
  34. 34.
    Sarkany RP, Burrows NP, Grant JW, Pye RJ, Norris PG. The pustular eruption of ulcerative colitis: a variant of Sweet’s syndrome? Br J Dermatol. 1998;138:365–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Yoon TY, Ahn GB, Yang TH, Shin HS. Sweet’s syndrome with abscess-like lesions in a patient with acute myelogenous leukemia. J Dermatol. 2000;27:794–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Horiguchi Y, Lee SG, Matsumoto I, Arima N, Fugiino H, Ohnuma Y, Imamura S. Abscess-forming neutrophilic dermatosis: report of three cases associated with hemopathies. Dermatology. 1998;197:174–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Cohen PR. Subcutaneous Sweet’s syndrome: a variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol. 2005;52:927–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Sutra-Loubet C, Carlotti A, Guillemette J, Wallach D. Neutrophilic panniculitis. J Am Acad Dermatol. 2004;50:280–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Chan MP, Duncan LM, Nazarian RM. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature. J Am Acad Dermatol. 2013;68:1006–15.CrossRefPubMedGoogle Scholar
  40. 40.
    Chen HC, Kao WY, Chang DM, Gao HW, Lai WY, Lai JH. Neutrophilic panniculitis with myelodysplastic syndromes presenting as pustulosis: case report and review of the literature. Am J Hematol. 2004;76:61–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Dompmartin A, Troussard X, Lorier E, Jacobs F, Reman O, Leroy D, Leporrier M. Sweet syndrome associated with acute myelogenous leukemia. Atypical form simulating facial erysipelas. Int J Dermatol. 1991;30:644–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Khatri ML, Taha M. Sweet’s syndrome associated with myelodysplastic syndrome presenting as periorbital cellulitis. Int J Dermatol. 2007;46:496–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Kroshinsky D, Alloo A, Rothschild B, Cummins J, Tan J, Montecino R, Hoang MP, Duncan L, Minh M, Sepehr A. Necrotizing Sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis. J Am Acad Dermatol. 2012;67:945–54.CrossRefPubMedGoogle Scholar
  44. 44.
    Surovy AM, Pelivani N, Hegyi I, Buettiker U, Beltraminelli H, Borradori L. Giant cellulitis-like Sweet syndrome, a new variant of neutrophilic dermatosis. JAMA Dermatol. 2013;149:79–83.CrossRefPubMedGoogle Scholar
  45. 45.
    Vignon-Pennamen MD, Wallach D. Cutaneous manifestations of neutrophilic disease. Dermatologica. 1991;183:255–64.CrossRefPubMedGoogle Scholar
  46. 46.
    Vignon-Pennamen MD. The extracutaneous involvement in the neutrophilic dermatoses. Clin Dermatol. 2000;18:339–47.PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Ferguson PJ, Chen S, Tayeh MK, Ochoa L, Leal SM, Pelet A, Munnich A, Lyonnet S, Majeed HA, El-Shanti H. Homozygous mutations in LIPN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet. 2005;42:551–7.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Marie I, Boyer A, Heron F, Joly P, Levesque H, Thomine E, Courtois H. Focal aseptic osteitis underlying neutrophilic dermatosis. Br J Dermatol. 1998;139:744–5.CrossRefPubMedGoogle Scholar
  49. 49.
    Gottlieb CC, Mishra A, Belliveau D, Green P, Heathcote JG. Ocular involvement in acute febrile neutrophilic dermatosis (Sweet syndrome): new cases and review of the literature. Surv Ophthalmol. 2008;53:219–26.CrossRefPubMedGoogle Scholar
  50. 50.
    Wilson DM, John GR, Callen JP. Peripheral ulcerative keratitis-an extracutaneous neutrophilic disorder: report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet’s syndrome with an excellent response to cyclosporine therapy. J Am Acad Dermatol. 1999;40:331–4.CrossRefPubMedGoogle Scholar
  51. 51.
    Bilgin AB, Tavas P, Turkoglu EB, Ilhan HD, Toru S, Apaydin KC. An uncommon ocular manifestation of Sweet syndrome: peripheral ulcerative keratitis and nodular scleritis. Arq Bras Oftalmol. 2015;78:53–5.CrossRefPubMedGoogle Scholar
  52. 52.
    Marie I, Levesque H, Joly P, Reumont G, Courville P, Baudrimont M, Baudion D, Cailleux N, Courtois H. Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol. 2001;44:137–9.PubMedCentralPubMedCrossRefGoogle Scholar
  53. 53.
    Mosnier E, Rousset P, Hugol D, Bouscary D, Aslangul E. Neutrophilic myositis sine dermatitis in a neutropenic patient with myelodysplastic syndrome. Ann Hematol. 2013;92:551–2.CrossRefPubMedGoogle Scholar
  54. 54.
    Astudillo L, Sailler L, Launay F, Josse AG, Lamant L, Couret B, Arlet-Suau E. Pulmonary involvement in Sweet’s syndrome: a case report and review of the literature. Int J Dermatol. 2006;45:677–80.CrossRefPubMedGoogle Scholar
  55. 55.
    Lawrence K, Hachem R, Wildes TM, Canizares M. A 54-year old man with a rash and pulmonary infiltrates. Chest. 2008;134:1340–3.CrossRefPubMedGoogle Scholar
  56. 56.
    Shugarman IL, Schmit JM, Sbicca JA, Wirk B. Easily missed extracutaneous manifestation of malignancy-associated Sweet’s syndrome: systemic inflammatory response syndrome. J Clin Oncol. 2011;29:e702–5.CrossRefPubMedGoogle Scholar
  57. 57.
    Hisanaga K, Iwasaki Y, Ytoyama Y. Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology. 2005;64:1756–61.CrossRefPubMedGoogle Scholar
  58. 58.
    Fain O, Mathieu E, Feton N, Sibony M, Sitbon M, Lejeune F, Thomas M. Intestinal involvement in Sweet’s syndrome. J Am Acad Dermatol. 1996;35:989–90.CrossRefPubMedGoogle Scholar
  59. 59.
    Li B, Ma Z, Xu X, Yin J, Wang X, Ren J, Wang S, Yang J, Ma T, Zhang Q, Yu J, Yan B. Multi-organ involvement of Sweet’s syndrome; a case report and literature review. Intern Med. 2015;54:339–43.CrossRefPubMedGoogle Scholar
  60. 60.
    Aractingi S, Mallet V, Pinquier L, Chosidow O, Vignon-Pennamen MD, Degos L, Dubertret L, Dombret H. Neutrophilic dermatoses during granulocytopenia. Arch Dermatol. 1995;131:1141–5.CrossRefPubMedGoogle Scholar
  61. 61.
    von den Driesch P, Weber MF. Are antibodies to neutrophilic cytoplasmic antigens (ANCA) a serologic marker for Sweet’s syndrome. J Am Acad Dermatol. 1993;29:666.CrossRefPubMedGoogle Scholar
  62. 62.
    Malone JC, Slone SP, Wills-Frank LA, Fearneyhough PK, Lear SC, Goldsmith LJ, Hood AF, Callen JP. Vascular inflammation (vasculitis) in Sweet syndrome: a clinicopathologic study of 28 biopsy specimens from 21 patients. Arch Dermatol. 2002;138:345–9.CrossRefPubMedGoogle Scholar
  63. 63.
    Rochael MC, Pantaleao L, Vilar EA, Zacaron LH, Spada EQ, Xavier MH, Rodrigues KS. Sweet’s syndrome: study of 73 cases, emphasizing histopathological findings. An Bras Dermatol. 2011;86:702–7.CrossRefPubMedGoogle Scholar
  64. 64.
    Requena L, Kutzner H, Palmedo G, Pascual M, Fernandez-Herrera J, Fraga J, Garcia-Diez A, Yus ES. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol. 2005;141:834–42.PubMedCentralPubMedCrossRefGoogle Scholar
  65. 65.
    Ghoufi L, Ortonne N, Ingen-Housz-Oro S, Barhoumi W, Begon E, Haioun C, Pautas C, Beckerich F, Robin C, Wolkenstein P, Cordonnier C, Chosidow O, Toma A. Histiocytoid Sweet syndrome is more frequently associated with myelodysplastic syndromes than the classical neutrophilic variant: a comparative series of 62 patients. Medicine. 2016;95:e3033.PubMedCentralPubMedCrossRefGoogle Scholar
  66. 66.
    Osio A, Battistella M, Feugeas JP, Cuccuini W, Noguera ME, Petrella T, Raffoux E, Janin A, Vignon Pennamen MD. Myelodysplasia cutis versus leukemia cutis. J Invest Dermatol. 2015;135:2321–4.CrossRefPubMedGoogle Scholar
  67. 67.
    Thompson DF, Montarella KE. Drug-induced Sweet’s syndrome. Ann Pharmacother. 2007;41:802–11.CrossRefPubMedGoogle Scholar
  68. 68.
    Su WP, Liu HN. Diagnostic criteria for Sweet’s syndrome. Cutis. 1986;37:167–74.PubMedGoogle Scholar
  69. 69.
    Kieffer C, Cribier B, Lipsker D. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine. 2009;88:23–31.CrossRefPubMedGoogle Scholar
  70. 70.
    Hau E, Vignon Pennamen MD, Battistella M, Saussine A, Bergis M, Cavelier-Balloy B, Janier M, Cordoliani F, Bagot M, Rybojad M, Bouaziz JD. Neutrophilic skin lesions in autoimmune connective tissue diseases: nine cases and a literature review. Medicine. 2014;93:e346.PubMedCentralPubMedCrossRefGoogle Scholar
  71. 71.
    Karadogan SK, Baskan EB, Alkan G, Saricaoglu H, Tunali S. Generalized Sweet syndrome lesions associated with Behçet disease: a true association or simply co-morbidity? Am J Clin Dermatol. 2009;10:331–5.CrossRefPubMedGoogle Scholar
  72. 72.
    Kawakami T, Ohashi S, Kawa Y, Takahama H, Ito M, Soma Y, Mizoguchi M. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of Sweet syndrome and patients with active Behçet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol. 2004;140:570–4.CrossRefPubMedGoogle Scholar
  73. 73.
    Waltz KM, Long D, Marks JG, Billingsley EM. Sweet’s syndrome and erythema nodosum. The simultaneous occurrence of 2 reactive dermatoses. Arch Dermatol. 1999;135:62–6.CrossRefPubMedGoogle Scholar
  74. 74.
    Burton JL. Sweet’s syndrome, pyoderma gangrenosum and acute leukemia. Br J Dermatol. 1980;102:239.CrossRefPubMedGoogle Scholar
  75. 75.
    Salmon P, Rademaker M, Edwards L. A continuum of neutrophilic disease occurring in a patient with ulcerative colitis. Australas J Dermatol. 1998;39:116–8.CrossRefPubMedGoogle Scholar
  76. 76.
    Castro-Fernandez M, Sanchez-Munoz D, Ruiz-Granados E, Merchante N, Corzo J. Coexistence of pyoderma gangrenosum and Sweet’s syndrome in a patient with ulcerative colitis. Am J Gastroenterol. 2007;102:2865–6.CrossRefPubMedGoogle Scholar
  77. 77.
    Wallach D. Les dermatoses neutrophiliques. Presse Med. 1991;20:105–7.PubMedGoogle Scholar
  78. 78.
    Wallach D, Vignon Pennamen MD. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol. 2006;55:1066–71.CrossRefPubMedGoogle Scholar
  79. 79.
    Scerri L, Zaki I, Allen BR. Pyoderma gangrenosum and subcorneal pustular dermatosis without monoclonal gammopathy. Br J Dermatol. 1994;130:398–9.CrossRefPubMedGoogle Scholar
  80. 80.
    Caucanas M, Heylen A, Rolland F, Müller G, Olemans C, Sass U, Vanhooteghem O. Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet’s syndrome: the concept of neutrophilic disease. Int J Dermatol. 2013;52:1185–8.CrossRefPubMedGoogle Scholar
  81. 81.
    Wang T, Liu H, Wang L, Guo Z, Li L. An unusual case of Sweet syndrome in a child: overlapping presentation with erythema elevatum diutinum. Am J Dermatopathol. 2014;36:e114–6.CrossRefPubMedGoogle Scholar
  82. 82.
    Cohen PR. Neutrophilic dermatoses occurring in oncology patients. Int J Dermatol. 2007;46:106–11.CrossRefPubMedGoogle Scholar
  83. 83.
    Buck T, Gonzalez LM, Lambert WC, Schwartz RA. Sweet’s syndrome with hematologic disorders: a review and reappraisal. Int J Dermatol. 2008;47:775–82.CrossRefPubMedGoogle Scholar
  84. 84.
    Kulasekararaj AG, Kordasti S, Basu T, Salisbury JR, Mufti GJ, du Vivier AW. Chronic relapsing remitting Sweet syndrome—a harbinger of myelodysplastic syndrome. Br J Haematol. 2015;170:649–56.CrossRefPubMedGoogle Scholar
  85. 85.
    Kazmi SM, Pemmaraju N, Patel KP, Cohen PR, Daver N, Tran KM, Ravandi F, Duvic M, Garcia-Manero G, Pierce S, Nazha A, Borthakur G, Kantarjian H, Cortes J. Characteristics of Sweet syndrome in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015;15:358–63.CrossRefPubMedGoogle Scholar
  86. 86.
    Vignon Pennamen MD, Juillard C, Rybojad M, Wallach D, Daniel MT, Morel P, Verola O, Janin A. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia. Arch Dermatol. 2006;142:1170–6.CrossRefPubMedGoogle Scholar
  87. 87.
    Vignon Pennamen MD, Aractingi S. Sweet’s syndrome and leukemia cutis: a common skin homing mechanism? Dermatology. 2003;206:81–4.CrossRefPubMedGoogle Scholar
  88. 88.
    Lee SJ, Park JK, Lee EY, Joo SH, Jung KC, Lee EB, Song YW, Yoon SS. Certain autoimmune manifestations are associated with distinctive karyotypes and outcomes in patients with myelodysplastic syndrome. A retrospective cohort study. Medicine. 2016;95:e3091.PubMedCentralPubMedCrossRefGoogle Scholar
  89. 89.
    Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34:918–23.CrossRefPubMedGoogle Scholar
  90. 90.
    Arbetter KR, Hubbard KW, Markovic SN, Gibson LE, Phyliky RL. Case of granulocyte colony-stimulating factor-induced Sweet’s syndrome. Am J Hematol. 1999;61:126–9.CrossRefPubMedGoogle Scholar
  91. 91.
    Draper BK, Robbins JB, Stricklin GP. Bullous Sweet’s syndrome in congenital neutropenia: association with pegfilgrastim. J Am Acad Dermatol. 2005;52:901–5.CrossRefPubMedGoogle Scholar
  92. 92.
    Al-Saad K, Khanani MF, Naqvi A, Krafchik B, Grant R, Pappo A. Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol. 2004;26:197–9.CrossRefPubMedGoogle Scholar
  93. 93.
    Varadarajan N, Boni A, Elder DE, Bagg A, Micheletti R, Perl AE, Rosenbach M. FLT3 inhibitor-associated neutrophilic dermatoses. JAMA Dermatol. 2016;152:480–2.CrossRefPubMedGoogle Scholar
  94. 94.
    Jovanovic M, Poljacki M, Vujanovic L, Duran V. Acute febrile neutrophilic dermatosis (Sweet’s syndrome) after influenza vaccination. J Am Acad Dermatol. 2005;52:367–8.CrossRefPubMedGoogle Scholar
  95. 95.
    Gunawardena DA, Gunawardena KA, Ratnayaka RM, Vasanthanathan NS. The clinical spectrum of Sweet’s syndrome (acute febrile neutrophilic dermatosis). A report of eighteen cases. Br J Dermatol. 1975;92:363–73.CrossRefPubMedGoogle Scholar
  96. 96.
    Kalai C, Brand R, Yu L. Minocycline-induced Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 2012;67:e289–91.CrossRefPubMedGoogle Scholar
  97. 97.
    Tintle S, Patel V, Ruskin A, Halasz C. Azacitidine: a new medication associated with Sweet syndrome. J Am Acad Dermatol. 2011;64:e77–9.CrossRefPubMedGoogle Scholar
  98. 98.
    Murase JE, Wu JJ, Theate I, Cole GW, Barr RJ, Dyson SW. Bortezomid-induced histiocytoid Sweet syndrome. J Am Acad Dermatol. 2009;60:496–7.CrossRefPubMedGoogle Scholar
  99. 99.
    Ayirookuzhi SJ, Ma L, Ramshesh P, Mills G. Imatinib-induced Sweet syndrome in a patient with chronic myeloid leukemia. Arch Dermatol. 2005;141:368–70.CrossRefPubMedGoogle Scholar
  100. 100.
    Gormley R, Wanat K, Elenitsas R, Giles J, McGettigan S, Schuchter L, Takeshita J. Ipilimumab-associated Sweet syndrome in a melanoma patient. J Am Acad Dermatol. 2014;71:e211–3.CrossRefGoogle Scholar
  101. 101.
    Azfar RS, Cohn J, Schaffer A, Kim EJ. Trimethoprim-sulfamethoxazole-induced Sweet syndrome. Arch Dermatol. 2009;145:215–6.PubMedGoogle Scholar
  102. 102.
    Banse C, Sobocinski V, Savoye G, Avenel G, Vittecoq O. Occurrence of Sweet syndrome under anti TNF. Clin Rheumatol. 2015;34:1993–4.CrossRefPubMedGoogle Scholar
  103. 103.
    Thieu KP, Rosenbach M, Xu X, Kist JM. Neutrophilic dermatosis complicating lenalidomide therapy. J Am Acad Dermatol. 2009;61:709–10.CrossRefPubMedGoogle Scholar
  104. 104.
    Bidinger JJ, Sky K, Battafarano DF, Henning JS. The cutaneous and systemic manifestations of azathioprine hypersensibility syndrome. J Am Acad Dermatol. 2011;65:184–91.CrossRefPubMedGoogle Scholar
  105. 105.
    Cyrus N, Stavert R, Mason AR, Ko CJ, Choi JN. Neutrophilic dermatosis after azathioprine exposure. JAMA Dermatol. 2013;149:592–7.CrossRefPubMedGoogle Scholar
  106. 106.
    Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013;45:202–10.CrossRefPubMedGoogle Scholar
  107. 107.
    Anzalone CL, Cohen PR. Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Curr Opin Hematol. 2013;20:26–35.CrossRefPubMedGoogle Scholar
  108. 108.
    Braun-Falco M, Ruzicka T. Skin manifestations in autoinflammatory syndromes. J Dtsch Dermatol Ges. 2011;9:232–46.PubMedGoogle Scholar
  109. 109.
    Oskay T, Anadolu R. Sweet’s syndrome in familial mediterranean fever: possible continuum of the neutrophilic reaction as a new cutaneous feature of FMF. J Cutan Pathol. 2009;36:901–5.CrossRefPubMedGoogle Scholar
  110. 110.
    Van Loon K, Gill RM, McMahon P, Chigurupati R, Siddiqi I, Fox L, Damon L, McCalmont TH, Jordan R, Wolf J. 20q-clonality in a case of oral Sweet syndrome and myelodysplasia. Am J Clin Pathol. 2012;137:310–5.CrossRefPubMedGoogle Scholar
  111. 111.
    Schadt CR, Callen JP. Management of neutrophilic dermatoses. Dermatol Ther. 2012;25:158–72.CrossRefPubMedGoogle Scholar
  112. 112.
    Case JD, Smith SZ, Callen JP. The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet’s syndrome. Cutis. 1989;44:125–9.PubMedGoogle Scholar
  113. 113.
    Inamadar AC, Anitha B. HIV-seropositive patient with Sweet’s syndrome and nodular scleritis, showing dramatic response after adding dapsone to systemic corticosteroid therapy. Int J Dermatol. 2008;47:836–8.CrossRefPubMedGoogle Scholar
  114. 114.
    Maillard H, Leclech C, Peria P, Avenel-Audran M, Verret JL. Colchicine for Sweet’s syndrome. A study of 20 cases. Br J Dermatol. 1999;140:565–6.CrossRefPubMedGoogle Scholar
  115. 115.
    Horio T, Inamura S, Danno K, Furukawa F, Ofuji S. Treatment of acute febrile neutrophilic dermatosis (Sweet’s syndrome) with potassium iodide. Dermatologica. 1980;160:341–7.CrossRefPubMedGoogle Scholar
  116. 116.
    Jeanfils S, Joly P, Young P, Le Corvaisier-Pieto C, Thomine E, Lauret P. Indomethacin treatment of eighteen patients with Sweet’s syndrome. J Am Acad Dermatol. 1997;36:436–9.CrossRefPubMedGoogle Scholar
  117. 117.
    Yamauchi PS, Turner L, Lowe NJ, Gindi V, Jackson JM. Treatment of recurrent Sweet’s syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol. 2006;54:S121–2.CrossRefPubMedGoogle Scholar
  118. 118.
    von den Driesch P, Steffan C, Zobe A, Hornstein OP. Sweet’s syndrome—therapy with cyclosporin. Clin Exp Dermatol. 1994;19:274–7.CrossRefPubMedGoogle Scholar
  119. 119.
    Gill HH, Leung AY, Trendell-Smith NJ, Yeung CK, Liang R. Sweet syndrome due to myelodysplastic syndrome: possible therapeutic role of intravenous immunoglobulin in addition to standard treatment. Adv Hematol. 2010;2010:328316.PubMedCentralPubMedGoogle Scholar
  120. 120.
    Kluger N, Gil-Bistes D, Guillot B, Bessis D. Efficacy of antiinterleukin-1 receptor antagonist anakinra (Kineret) in a case of refractory Sweet’s syndrome. Dermatology. 2011;222:123–7.CrossRefPubMedGoogle Scholar
  121. 121.
    Browning CE, Dixon JE, Malone JC, Callen JP. Thalidomide in the treatment of recalcitrant Sweet’s syndrome associated with myelodysplasia. J Am Acad Dermatol. 2005;53:S135–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Pathology DepartmentAPHP Hôpital Saint LouisParisFrance

Personalised recommendations